Graham Capital Management, L.P. Fulcrum Therapeutics, Inc. Transaction History
Graham Capital Management, L.P.
- $5.17 Billion
- Q2 2025
A detailed history of Graham Capital Management, L.P. transactions in Fulcrum Therapeutics, Inc. stock. As of the latest transaction made, Graham Capital Management, L.P. holds 12,052 shares of FULC stock, worth $106,419. This represents 0.0% of its overall portfolio holdings.
Number of Shares
12,052
Previous 166,243
92.75%
Holding current value
$106,419
Previous $478,000
82.85%
% of portfolio
0.0%
Previous 0.01%
Shares
8 transactions
Others Institutions Holding FULC
# of Institutions
130Shares Held
55.6MCall Options Held
886KPut Options Held
93.3K-
Ra Capital Management, L.P. Boston, MA10.2MShares$90.3 Million1.54% of portfolio
-
Tcg Crossover Management, LLC Palo Alto, CA5.25MShares$46.4 Million7.36% of portfolio
-
Suvretta Capital Management, LLC New York, NY5.08MShares$44.9 Million1.2% of portfolio
-
Black Rock Inc. New York, NY4.8MShares$42.4 Million0.0% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.59MShares$40.5 Million0.06% of portfolio
About Fulcrum Therapeutics, Inc.
- Ticker FULC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,038,900
- Market Cap $460M
- Description
- Fulcrum Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing products for improving the lives of patients with genetically defined diseases in the areas of high unmet medical need in the United States. Its product candidates are losmapimod, a small molecule for the treatment of facioscapulohumeral muscular dystro...